Should We Stick with Surgical Glues? The Incidence of Dermatitis after 2-Octyl Cyanoacrylate Exposure in 102 Consecutive Breast Cases
| Autor: | Jamie Parkerson, Julia R Nunley, Lauren C. Nigro, Nadia P. Blanchet |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Allergy business.industry Breast surgery medicine.medical_treatment Incidence (epidemiology) 030230 surgery medicine.disease law.invention Surgery 2-Octyl cyanoacrylate Occlusive dressing 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Cyanoacrylate law 030220 oncology & carcinogenesis medicine business Prospective cohort study Contact dermatitis |
| Zdroj: | Plastic and Reconstructive Surgery. 145:32-37 |
| ISSN: | 0032-1052 |
| DOI: | 10.1097/prs.0000000000006321 |
| Popis: | Skin adhesives have become standard in wound closure as alternatives to traditional sutures or as sterile occlusive dressings after surgery of all types. The literature is replete with case reports of contact dermatitis following exposure to cyanoacrylate-based adhesives, such as 2-octyl cyanoacrylate. Nonetheless, it has been the impression of the senior author and others that the incidence of allergic and/or contact dermatitis is much higher than commonly considered. The authors prospectively studied 102 consecutive patients who underwent breast surgery performed by the senior author with 2-octyl cyanoacrylate placed over incisions as an occlusive dressing. Two patients with a known glue allergy did not receive cyanoacrylate at surgery but were scratch tested to confirm the diagnosis. All patients were followed postoperatively. Twelve patients went on to develop significant dermatitis postoperatively after glue placement. Cyanoacrylate was confirmed as the cause of all rashes by allergy scratch testing for a total incidence of 14 percent (14 patients). Given the popularity of cyanoacrylate products across emergency rooms, clinics, and operating rooms, awareness of the true incidence of these reactions may caution against their use in the future. CLINICAL QUESTION/LEVEL OF EVIDENCE:: Therapeutic, IV. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|